What is Phathom Pharmaceuticals, Inc.'s current debt?

Phathom Pharmaceuticals, Inc. (PHAT) reported current debt of $0 in Q1 2026.

What is the long-term trend for Phathom Pharmaceuticals, Inc.'s current debt?

Over 4 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s current debt has grown at a -100.0% compound annual growth rate (CAGR), from $7.35M to $0.

What does current debt mean?

The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.

Phathom Pharmaceuticals, Inc. PHAT Current Debt

Current Debt at other companies

Opko HealthOPK

$1.53M+7.2%

AMP

Amphastar PharmaceuticalsAMPH

$1.67M+646%

OrganonOGN

$16M-20.0%

AbbVieABBV

$0-100%

Bristol-Myers SquibbBMY

$2.31B-35.1%

AbbottABT

$4.41B+771%

Other financials

Income statement

See full

Revenue$58.3M+104%

Gross profit$46.3M+86.8%

Operating income-$15.5M+80.4%

Net income-$30.4M+67.8%

EPS (diluted)-$0.37+71.8%

Balance sheet

See full

Cash & equivalents$180.9M-14.8%

Total debt$166.3M-18.3%

Total equity-$337.0M+0.4%

Total assets$305.1M+3.7%

Cash flow

See full

Operating cash flow-$15.6M+81.6%

CapEx$61.0K+239%

Free cash flow-$15.7M+81.5%

Valuation

See full

Market cap$846.21M+16.3%

Enterprise value$831.61M+15.7%

P/S4.1×-4.8×

Profitability

See full

Gross margin84.9%-1.3pp

Operating margin-47.1%-21.9pp

Net margin-76.8%-34.5pp

FCF margin-47.7%-22.1pp

Returns & leverage

See full

Return on equity-147.9%—

Debt / equity5.6×—

Current ratio2.2×-1.4×

Where this comes from

Reported directly by Phathom Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.

The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phathom Pharmaceuticals, Inc.'s current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Phathom Pharmaceuticals, Inc.'s current debt?: Phathom Pharmaceuticals, Inc. (PHAT) reported current debt of $0 in Q1 2026.
What is the long-term trend for Phathom Pharmaceuticals, Inc.'s current debt?: Over 4 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s current debt has grown at a -100.0% compound annual growth rate (CAGR), from $7.35M to $0.
What does current debt mean?: The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.